Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society-Reference-Cited by-同舟云学术

Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society

Published:2023-06 Issue: Volume:374 Page:107-120
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Kronenberg Florian^ORCID,Mora Samia,Stroes Erik S.G.,Ference Brian A.,Arsenault Benoit J.,Berglund Lars,Dweck Marc R.,Koschinsky Marlys L.,Lambert Gilles,Mach François,McNeal Catherine J.,Moriarty Patrick M.,Natarajan Pradeep,Nordestgaard Børge G.,Parhofer Klaus G.,Virani Salim S.,von Eckardstein Arnold,Watts Gerald F.,Stock Jane K.,Ray Kausik K.,Tokgözoğlu Lale S.,Catapano Alberico L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference136 articles.

1. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement;Kronenberg;Eur. Heart J.,2022

2. Lipoprotein(a) beyond the kringle IV repeat polymorphism: the complexity of genetic variation in the LPA gene;Coassin;Atherosclerosis,2022

3. Lipoprotein(a) and cardiovascular and valvular diseases: a genetic epidemiological perspective;Arsenault;Atherosclerosis,2022

4. Genetic associations with valvular calcification and aortic stenosis;Thanassoulis;N. Engl. J. Med.,2013

5. Lipoprotein(a) reduction in persons with cardiovascular disease;Tsimikas;N. Engl. J. Med.,2020

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aspirin use in patients with elevated lipoprotein(a): Impact on cardiovascular events and bleeding;Current Problems in Cardiology;2024-11

2. Lipid-Lowering Treatment Gaps in Patients after Acute Myocardial Infarction: Using Global Database TriNetX;Medicina;2024-09-02

3. Lipoprotein (a) and lipid-lowering treatment from the perspective of a cardiac surgeon. An impact on the prognosis in patients with aortic valve replacement and after heart transplantation;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-09

4. Lipoprotein(a) - gaining clinical importance as a cardiovascular risk factor. Current state of medical knowledge.;Prospects in Pharmaceutical Sciences;2024-08-14

5. Early health technology assessment of gene silencing therapies for lowering lipoprotein(a) in the secondary prevention of coronary heart disease;Journal of Clinical Lipidology;2024-08